Radboud Universitair Medisch Centrum

Nijmegen, Gelderland 6525 GA

3 studies enrolling now · 11 studies all time

What they study most

Adjuvant, Advanced or Metastatic NSCLS With Exon 20 Insertion Mutation, Blindness, Colitis, Ulcerative, Duchenne Muscular Dystrophy, EGFR, Early Stage Lung Cancer, Exon 20, Eye Diseases, Eye Diseases, Hereditary, Eye Disorders Congenital, Immunoglobulin A Nephropathy

Studies at this site

• Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor — Recruiting now
• Efficacy And Safety Evaluation of Glepaglutide in Treatment of SBS — Recruiting now
• REZILIENT3 (REsearching ZIpaLertinib In Egfr Non-small Cell Lung Cancer Tumors) — Running, not enrolling
• A Study to Assess the Efficacy and Safety of Zipalertinib Versus Placebo for Adjuvant Treatment in Participants With Stage IB-IIIA NSCLC With Uncommon EGFR Mutations, Following Complete Tumor Resection — Running, not enrolling
• Trial of Sibeprenlimab in the Treatment of Immunoglobulin A Nephropathy (IgAN) — Enrolling by invitation
• VE202 in Patients With Mild-to-Moderate Ulcerative Colitis — Stopped early
• Study to Assess the Efficacy and Safety of Viltolarsen in Ambulant Boys With DMD (RACER53) — Completed
• Phase 3 Trial of Pamrevlumab or Placebo With Systemic Corticosteroids in Participants With Non-ambulatory Duchenne Muscular Dystrophy (DMD) — Stopped early
• A Study Evaluating the Efficacy and Safety of ABP 959 Compared With Eculizumab in Adult Participants With PNH — Completed
• ENHANCE: Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Response to or an Intolerance to Ursodeoxycholic Acid (UDCA) — Completed
• Natural History Study of CEP290-Related Retinal Degeneration — Completed